Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 533
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 375.8
定的其他幾家藥店,在品種配置、冷鏈管理等方面稍有遜色?!爸灰幤吩趦?nèi)部可以流轉(zhuǎn),能不能以集團(tuán)而非個體作為遴選標(biāo)準(zhǔn)?這樣才更好保障針劑類等冷鏈藥品轉(zhuǎn)運(yùn)的安全性?!彼f。 南京醫(yī)藥股份有限公司DTP(直接
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 183.6
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 715.9
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 555.6
指數(shù)累計(jì)下跌4.84%,恒生指數(shù)累計(jì)下跌3.56%。 藥店股普漲 醫(yī)藥商業(yè)板塊領(lǐng)漲,多只醫(yī)藥流通股、藥店股本周實(shí)現(xiàn)上漲。本周累計(jì),南京醫(yī)藥(600713.SH)上漲10.90%,第一醫(yī)藥
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 390.1
圖片
視頻
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 533
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 375.8
熱評:
定的其他幾家藥店,在品種配置、冷鏈管理等方面稍有遜色?!爸灰幤吩趦?nèi)部可以流轉(zhuǎn),能不能以集團(tuán)而非個體作為遴選標(biāo)準(zhǔn)?這樣才更好保障針劑類等冷鏈藥品轉(zhuǎn)運(yùn)的安全性?!彼f。 南京醫(yī)藥股份有限公司DTP(直接
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 183.6
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 715.9
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 555.6
熱評:
指數(shù)累計(jì)下跌4.84%,恒生指數(shù)累計(jì)下跌3.56%。 藥店股普漲 醫(yī)藥商業(yè)板塊領(lǐng)漲,多只醫(yī)藥流通股、藥店股本周實(shí)現(xiàn)上漲。本周累計(jì),南京醫(yī)藥(600713.SH)上漲10.90%,第一醫(yī)藥
熱評:
Nanjing Pharmaceutical Company Limited (南京醫(yī)藥股份有限公司) (600713.SH) reported a net profit of 390.1
熱評: